Aneurysm Study of Pipeline in an Observational Registry

Inclusion Criteria

• •(All sites, All countries)
• •1. At least 1 Pipeline placed for treatment of an ICA
• •2. Patient or patient's Legally Authorized Representative (LAR) has signed an IRB- or EC-approved informed consent form, if required
• •3. Patient is willing and able to comply with follow-up visits
• •4US) Subjects who are age 22 or higher 5US) IA of at least 10 mm in maximum dimension along the internal carotid artery between the petrous and superior hypophyseal segments
• •4C) In Canada, the Pipeline™ Embolization Device is intended for use with or without embolic coils for the treatment of complex intracranial aneurysms that are not amenable to treatment with surgical clipping.
• •5C) Canadian licensing/approval is limited to devices that are between 3.25 mm and 5.00 mm in diameter.
• •4F) Unruptured IA, saccular or fusiform with an aneurysm sac diameter \> 15mm and not treatable with other current therapies ( EVT with coils with or without assisting system (intracranial stent) or balloon remodeling, or surgery) due to its specific morphology.
• •5F) IA previously treated with unruptured recanalization of the aneurismal sac \> 7 mm, not treatable with conservative treatment.